Withdrawal following sufentanil/propofol and sufentanil/midazolam: Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids

Intensive Care Medicine

Volumn 31, Issue 3, 2005, Pages 380-387

  Korak Leiter, Maria ^a   Likar, Rudolf ^a   Oher, Michael ^a   Trampitsch, Ernst ^a   Ziervogel, Gerda ^a   Levy, Joseph V ^b   Freye, Enno C ^c  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

^b UNIVERSITY OF THE PACIFIC   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

EEG spectral edge frequency; Intensive care unit; Met enkephalin; Somatosensory evoked potentials; Sufentanil; Withdrawal; endorphin

Indexed keywords

BETA ENDORPHIN; HYPNOTIC SEDATIVE AGENT; METENKEPHALIN; MIDAZOLAM; NARCOTIC ANALGESIC AGENT; PROPOFOL; SUFENTANIL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONSCIOUS SEDATION; DELIRIUM; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HEART RATE; HUMAN; INTENSIVE CARE; MALE; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE CARE; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; BETA-ENDORPHIN; BLOOD PRESSURE; CONSCIOUS SEDATION; DELIRIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; ENKEPHALIN, METHIONINE; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; MALE; MIDAZOLAM; MIDDLE AGED; POSTOPERATIVE CARE; PROPOFOL; SUBSTANCE WITHDRAWAL SYNDROME; SUFENTANIL;

EID: 23044461984     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-005-2579-3     Document Type: Article

References (61)

1. Aitkenhead AR (1989) Analgesia and sedation in intensive care. Br J Anaesth 63:196–206
2. Ball M, McQuay HJ, Moore RA, Allen MC, Fischer A, Sear J (1987) Renal failure and the use of morphine in the intensive care. Lancet 1:784–786
3. Pesau B, Falger S, Berger E, Weiman J, Schuster E, Leithner C, Frass M (1992) Influence of age on outcome of mechanically ventilated patients in an intensive care unit. Crit Care Med 20:489–492
4. Shafer A, White P, Schüttler J, Rosenthal MH (1983) Use of fentanyl infusion in the intensive care unit: tolerance to its anesthetic effects? Anesthesiology 59:245–248
5. Mangano DT, Siciliano D, Hollenberg M, Leung JM, Browener WS, Goehner P, Merrick S, Verrier E (1992) Postoperative myocardial ischemia-therapeutic trials using intensive analgesia following surgery. Anesthesiology 76:342–353
6. Bredas P, Grounds M, Roedler G, Torres KM (1998) Optimizing analgesia in the intensive care unit. In: Maze M, Morrison P (eds) Redefining sedation. Royal Society of Medicine, London, pp. 51–61
7. Ohlendorf H, Jong MD, Steenhoek A, Janknegt R (1988) Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability? Clin Pharmacol Ther 43:263–269
8. Tonner PH, Scholz J (1996) Clinical perspectives of alpha-2 adrenoreceptor agonists. Curr Opinion Anaesth 9:471–480
9. Bjoerkqvist SE (1975) Clonidine in alcohol withdrawal. Acta Psychiat Scand 52:256
10. Vining DH, Kosten TR, Kleber HD (1988) Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addict 63:567–575
11. Nadelson T (1976) The psychiatrist in the surgical intensive care unit. I. Postoperative delirium. Arch Surg 111:113–117
12. Tobias JD (2000) Tolerance withdrawal and physical dependency after long-term sedation and analgesia of children in pediatric intensive care unit. Crit Care Med 28:2122–2132
13. Arnold JH, Truog RD, Orav EJ, Scavone JM, Hershenson MB (1990) Tolerance and dependance in neonates sedated with fentanyl during extracoperal membrane oxygenation. Anesthesiology 73:1136–1140
14. Cammarano WB, Pittet JF, Weitz S, Schlobohm RM, Marks JD (1998) Acute withdrawal syndrome related to the administration of analgesic and sedative medication in adult intensive care unit patients. Crit Care Med 26:676–684
15. Byatt CM, Lewis LD, Dawling S, Cochrane GM (1984) Accumulation of midazolam after repeated dosage in patients receiving mechanical ventilation in an intensive care unit. Br Med J 289:799–800
16. Zander J (1991) Wirkungen und Nebenwirkungen von Opioiden und Neuroleptika bei kontinuierlicher Anwendung während operativer Intensivtherapie. In: Henschel W (ed) I. Europäisches Analgesieforum-Die Analgesie im Mittelpunkt der Anästhesie München Wien Baltimore Urban & Schwarzenberg pp. 148–157
17. Hofbauer R, Tesinsky P, Hammerschmidt V, Kofler J, Staudinger T, Kordova H, Vrastiolovat M, Fruss M, Freye E (1999) No reduction in the sufentanil requirement of elderly patients undergoing ventilatory support in the medical intensive care unit. Eur J Anaesthesiol 16:702–707
18. Ramsey MAE, Savage TM, Simpson BNRJ, Goodwin R (1974) Controlled sedation with alphaloxone-alphadone. Br Med J II:656–659
19. Jasinski DR (1977) Assessment of the abuse potentiality of morphine-like drugs. In: Martin WR (ed) Drug Addiction. Springer, Berlin Heidelberg New York, pp. 197–258
20. Freye E, Levy JV, Partecke L (2004) Use of gabapentin for attenuation of symptoms following rapid opiate detoxification (ROD)-correlation with neurophysiological parameters. Clin Neurophysiol 34:81–89
21. Buchsbaum MS, Davis GC, Naber D, Pickar D (1983) Pain enhances naloxone-induced hyperalgesia in humans as assessed by somatosensory-evoked potentials. Psychopharmacology 79:99–103
22. Allison T, McCarthy G, Wood CC (1992) The relationship between human long-latency somatosensory evoked potentials recorded from the cortical surface and from the scalp. Electroenceph Clin Neurophysiol 84:301–314
23. Friedman DP, Murray EA (1986) Thalamic connectivity of the second somatosensory area and neighboring somatosensory fields of the lateral sulcus of the Macaque. J Comp Neurol 252:348–373
24. Kenshalo Jr DR, Isensee O (1983) Responses of primates SI cortical neurons to noxious stimuli. J Neurophysiol 50:1479–1496
25. Garcia-Larrera L, Font M, Valeriani M (2003) Brain generators of human laser-evoked potentials. From dipoles to functional significance. Neurophysiol Clin 6:279–292
26. Freye E, Neruda B, Falke K (1991) EEG-Powerspektren und evozierte Potentiale unter Alfentanil/Midazolam-Analgosedierung bei Intensivpatienten. Anästhesiol Intensivmed Notfallmed Schmerzther 26:384–388
27. Bailey PL, Streisand JB, Pace NL, Bayless J, Stanley TH (1986) Sufentanil produces shorter lasting respiratory depression and longer lasting analgesia than equipotent doses of fentanyl in human volunteers. Anesthesiology 65:493
28. Bailey PL, Streisand JB, East KA, Iser S, Hansen TW, Posthuma EFM, Rozendaal FM, Stanley TH (1990) Differences in magnitude and duration of opioid induced respiratory depression and analgesia with fentanyl and sufentanil. Anesth Analg 70:8–15
29. 20 in patients undergoing general surgery. A blind study. Anesthesiology 69:A213
30. Tryba M (1993) Management of withdrawal symptoms. Clin Intens Care 4:S24-S26
31. Boulard G, Maurette P, Pouguet P, Dautheribes M, Viallefont E, Besse JL, Dabadie P, Sabathie M (1983) Syndrome abstinence après arrèt de la sedation par fentanyl en neuro-réanimation. Ann Fr Anesth Reanim 2:100–101
32. Mao J, Price DD, Mayer DJ (1995) Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62:259–274
33. Mayer DJ, Mao J, Price DD (1995) The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain 61:365–374
34. Niemegeers CJE, Schellenkens KHL, van Bever WFM, Janssen PAJ (1976) Sufentanil a very potent and extremely safe intravenous morphine-like compound in mice rats and dogs. Arzneim Forsch/Drug Res 216:1551–1556
35. Luger TJ, Hill HF, Schlager A (1992) Can midazolam diminish sufentanil analgesia in patients with major trauma? A retrospective study with 43 patients. Drug Metab Drug Interact 10:177–184
36. Kissin I, Lee SS, Arthur GR, Bradley EL (1997) Effect of midazolam on development of acute tolerance to alfentanil: the role of pharmacokinetic interactions. Anesth Analg 85:182–187
37. Luger TJ, Hayashi T, Weiss CG, Hill HF (1995) The spinal potentiation effect and the supraspinal inhibitory effect of midazolam on opioid-induced analgesia in rats. Eur J Pharmacol 275:153–162
38. Luger TJ, Hayashi T, Lawrence I, Hill HF (1994) Mechanisms of the influence of midazolam on morphine antinociception at spinal and supraspinal levels in rats. Eur J Pharmacol 271:421–431
39. Palaoglu O, Ayhan IH (1986) The possible role of benzodiazepine receptors in morphine analgesia. Pharmacol Biochem Behav 25:215–217
40. Daghero AM, Bradley EL, Kissin I (1987) Midazolam antagonizes the analgesic effect of morphine in rats. Anesth Analg 66:944–947
41. Gear RW, Miaskowski C, Heller PH, Paul SM, Gordon NC, Levine JD (1997) Benzodiazepine mediated antagonism of opioid analgesia. Pain 71:25–29
42. Schwieger IA, Hall RI, Hug CCH (1991) Less than additive antinociceptive interaction between midazolam and fentanyl in enflurane-anesthetized dogs. Anesthesiology 74:1060–1066
43. Hughes MA, Glass PSA, Jacobs JR (1992) Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 76:334–341
44. Aitkenhead AR, Peppermann ML, Willats SM, Coates PD, Park GR, Bodenham AR, Collins SH, Smith MB, Ledingham IM, Wallace PGM (1989) Comparison of propofol and midazolam for sedation in critically ill patients. Lancet II:704–709
45. Cockshott ID (1985) Propofol (Diprivan) pharmacokinetics and metabolism-an overview. Postgrad Med J 61:45–50
46. Kress JP, Pohlmann AS, O‘Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 34:1471–1477
47. Tobias JD, Berkenbosch JW (2004) Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 97:451–455
48. Goldstein DB, Goldstein A (1961) Possible role of enzyme inhibition and repression in drug tolerance and addiction. Biochem Pharmac 8:48–53
49. Freye E, Levy JV, Partecke L (2003) Abstinence symptoms following rapid opiate detoxification: anesthesia technique monitoring and postdetox therapy. Avicenna 2:35–44
50. Redmond DE, Hwang YH (1982) The primate locus coeruleus and affects of clonidine on opiate withdrawal. J Clin Psychiatr 43:25–31
51. Tanaka C, Inagaki C, Fuhwara H (1976) Labeled noradrenaline release from rat cerebral cortex following electrical stimulation of locus coeruleus. Brain Res 106:384–389
52. Jarrot B, Conway EL, Maccarone C, Lewis SJ (1987) Clonidine: understanding its disposition sites and mechanism of action. Clin Exp Pharmacol Physiol 14:471–479
53. Foote SL, Bloom FE, Aston-Jones G (1983) Nucleus locus ceruleus: New evidence for anatomical and physiological specificity. Physiol Rev 63:844–895
54. Fleischhacker WW (1988) Dependence potentials of benzodiazepines. Lancet II:504–511
55. Sury MR, Billingham I, Russell GN, Hopkins CS, Thormington R, Vivori E (1989) Acute benzodazepine withdrawal syndrome after midazolam infusions in children. Crit Care Med 17:301–302
56. Au J, Walker EA, Scott DH (1990) Withdrawal syndrome after propofol infusion. Anaesthesia 45:741–742
57. Farina ML, Levati A, Tognoni GA (1981) A multicentre study of ICU drug utilization. Intensive Care Med 7:125–131
58. Poser W, Poser S (1986) Abusus und Abhängigkeit von Benzodiazepinen. Internist 27:738–745
59. Priebe S (1988) Resumption of benzodiazepine use after withdrawal in hospital- a follow up study. Pharmacopsychiatry 21 353–359
60. Lader M, Morton S (1991) Benzodiazepine problems. Brit J Addict 86:823–828
61. Freye E, Likar R, Korak-Leitner M, Latasch L (1999) Emergence of withdrawal after sufentanil/propofol is faster than after sufentanil/midazolam in ICU-patients. Anesthesiology 91:A393